Literature DB >> 31525303

Concurrent participation in screening for cervical, breast, and bowel cancer in England.

Matejka Rebolj1,2, Dharmishta Parmar2, Roberta Maroni2, Oleg Blyuss2,3, Stephen W Duffy2.   

Abstract

Objectives: To determine how many women participate in all three recommended cancer screening programmes (breast, cervical, and bowel). During their early 60s, English women receive an invitation from all the three programmes.
Methods: For 3060 women aged 60–65 included in an England-wide breast screening case–control study, we investigated the number of screening programmes they participated in during the last invitation round. Additionally, using the Fingertips database curated by Public Health England, we explored area-level correlations between participation in the three cancer screening programmes and various population characteristics for all 7014 English general practices with complete data.
Results: Of the 3060 women, 1086 (35%) participated in all three programmes, 1142 (37%) in two, 526 (17%) in one, and 306 (10%) in none. Participation in all three did not appear to be a random event (p < 0.001). General practices from areas with less deprivation, with more patients who are carers or have chronic illnesses themselves, and with more patients satisfied with the provided service were significantly more likely to attain high coverage rates in all programmes. Conclusions: Only a minority of English women is concurrently protected through all recommended cancer screening programmes. Future studies should consider why most women participate in some but not all recommended screening.

Entities:  

Keywords:  Breast cancer; bowel cancer; cervical cancer; participation; screening

Mesh:

Year:  2019        PMID: 31525303     DOI: 10.1177/0969141319871977

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  4 in total

1.  Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.

Authors:  Glen B Taksler; Elisabeth F P Peterse; Isarah Willems; Kevin Ten Haaf; Erik E L Jansen; Inge M C M de Kok; Nicolien T van Ravesteyn; Harry J de Koning; Iris Lansdorp-Vogelaar
Journal:  JAMA Oncol       Date:  2021-06-01       Impact factor: 31.777

2.  Why do people take part in atrial fibrillation screening? Qualitative interview study in English primary care.

Authors:  Sarah Hoare; Alison Powell; Rakesh Narendra Modi; Natalie Armstrong; Simon J Griffin; Jonathan Mant; Jenni Burt
Journal:  BMJ Open       Date:  2022-03-16       Impact factor: 2.692

3.  Cytology interpretation after a change to HPV testing in primary cervical screening: Observational study from the English pilot.

Authors:  Matejka Rebolj; Christopher S Mathews; Karin Denton
Journal:  Cancer Cytopathol       Date:  2022-04-04       Impact factor: 4.264

4.  Cell-Free DNA-Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled Trial.

Authors:  Richard D Neal; Peter Johnson; Christina A Clarke; Stephanie A Hamilton; Nan Zhang; Harpal Kumar; Charles Swanton; Peter Sasieni
Journal:  Cancers (Basel)       Date:  2022-10-01       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.